NEW ISSUE: Insights About The Opioid Crisis
Health Affairs
Since 1981, Health Affairs has been the leading journal of health policy thought and research.
Greetings,
Last week, Health Affairs released their September 2025 theme issue providing insights on the opioids crisis.
Today, we will take a closer look at a few of the papers featured.
Also, let's highlight an upcoming live podcast taping and September events on the opioid crisis and prior authorization.
As always, sign up for our free daily and weekly newsletters to never miss an event, an article, podcast, or health policy brief.
S Y S T E M I C B A R R I E R S
The Opioid Crisis: Scaling Up Treatment And Harm Reduction Programs To Reach More People Who Would Benefit by Brendan Saloner and Pooja Lagisetty, MD, MSc
G A P S I N C A R E
Fewer Than 1 In 3 Adolescents With Past-Year Opioid Use Disorder Received Substance Use Treatment, 2022–23 by Manuel Cano et al.
Black, Hispanic, And Asian Adults In The US Had Substantially Lower Engagement On The Naloxone Care Cascade, 2024 by Lindsay Allen et al.
C A R E B Y P A Y E R
The Quality Of Opioid Use Disorder Treatment In Medicare Is Low And Lags Behind Medicaid by Tami Mark et al.
Medicaid Enrollees With Opioid Use Disorder Were More Likely To Receive Medication Treatment Than Commercial Enrollees by Karen Shen et al.
Join us on October 22 for an open access live recording of A Health Podyssey featuring Jennifer Kao discussing her upcoming paper that explores the impact of risk evaluation and mitigation strategies on generic approvals of US pharmaceutical products.
The Current Opioids Policy Landscape & What’s Ahead
Join Health Affairs September 17 for a virtual event with Brendan Saloner and Joshua Sharfstein discussing the current opioids policy landscape and what lies ahead.
Prior Authorization: Current State and Potential Reform
Join Health Affairs on September 23 for an exclusive Insider virtual event exploring prior authorization. Speakers include Mark Fendrick , Ravi Gupta , Michael Anne Kyle , and Christina Andrews .
Become an Insider today to get access to all of our exclusive events.